David N. Louis
Brigham and Women's Hospital · 617 works · 143,140 citations · h-index 135
Top works
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
- The 2007 WHO Classification of Tumours of the Central Nervous System
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- Patterns of somatic mutation in human cancer genomes
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
- Erratum to: The 2007 WHO classification of tumours of the central nervous system
- Prediction of central nervous system embryonal tumour outcome based on gene expression
- Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic Oligodendrogliomas
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- The WHO Classification of Tumors of the Nervous System
- Intragenic ERBB2 kinase mutations in tumours
- Malignant astrocytic glioma: genetics, biology, and paths to treatment
- AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
- Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
- The repertoire of mutational signatures in human cancer
- I nternational S ociety of N europathology‐ H aarlem C onsensus G uidelines for N ervous S ystem T umor C lassification and G rading
- Epidermal growth factor receptor and Ink4a/Arf
- Pan-cancer analysis of whole genomes
- A Hypermutation Phenotype and Somatic MSH6 Mutations in Recurrent Human Malignant Gliomas after Alkylator Chemotherapy
- Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine